日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis

2 型糖尿病合并慢性肾脏病患者低钾血症:非奈利酮的作用——一项 FIDELITY 分析

Pitt, Bertram; Agarwal, Rajiv; Anker, Stefan D; Rossing, Peter; Ruilope, Luis; Herzog, Charles A; Greenberg, Barry; Pecoits-Filho, Roberto; Lambelet, Marc; Lawatscheck, Robert; Scalise, Andrea; Filippatos, Gerasimos

Validation of the Klinrisk chronic kidney disease progression model in the FIDELITY population

在 FIDELITY 人群中验证 Klinrisk 慢性肾脏病进展模型

Tangri, Navdeep; Ferguson, Thomas; Leon, Silvia J; Anker, Stefan D; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M; Farjat, Alfredo E; Farag, Youssef M K; Schloemer, Patrick; Lawatscheck, Robert; Rohwedder, Katja; Bakris, George L

Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance

根据基线胰岛素抵抗情况,非奈利酮治疗慢性肾病合并2型糖尿病患者的疗效

Ebert, Thomas; Anker, Stefan D; Ruilope, Luis M; Fioretto, Paola; Fonseca, Vivian; Umpierrez, Guillermo E; Birkenfeld, Andreas L; Lawatscheck, Robert; Scott, Charlie; Rohwedder, Katja; Rossing, Peter

Prevalence of Chronic Kidney Disease in Type 1 Diabetes Among Adults in the U.S

美国1型糖尿病成人慢性肾脏病患病率

Rossing, Peter; Groop, Per-Henrik; Singh, Rakesh; Lawatscheck, Robert; Tuttle, Katherine R

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

非那利酮对2型糖尿病合并慢性肾脏病相关复合心血管风险的影响

Agarwal, Rajiv; Pitt, Bertram; Rossing, Peter; Anker, Stefan D; Filippatos, Gerasimos; Ruilope, Luis M; Kovesdy, Csaba P; Tuttle, Katherine; Vaduganathan, Muthiah; Wanner, Christoph; Bansilal, Sameer; Gebel, Martin; Joseph, Amer; Lawatscheck, Robert; Bakris, George L

Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis

菲达利酮治疗4期慢性肾病合并2型糖尿病患者的疗效:一项FIDELITY亚组分析

Sarafidis, Pantelis; Agarwal, Rajiv; Pitt, Bertram; Wanner, Christoph; Filippatos, Gerasimos; Boletis, John; Tuttle, Katherine R; Ruilope, Luis M; Rossing, Peter; Toto, Robert; Anker, Stefan D; Liu, Zhi-Hong; Joseph, Amer; Ahlers, Christiane; Brinker, Meike; Lawatscheck, Robert; Bakris, George

Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use

非奈利酮用于治疗各种慢性肾病和 2 型糖尿病患者,包括使用胰高血糖素样肽-1 受体激动剂的患者。

Rossing, Peter; Agarwal, Rajiv; Anker, Stefan D; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M; Fonseca, Vivian; Umpierrez, Guillermo E; Caramori, Maria Luiza; Joseph, Amer; Lambelet, Marc; Lawatscheck, Robert; Bakris, George L

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

对中晚期慢性肾脏病合并难治性高血压患者使用非奈利酮和螺内酯的比较性事后分析

Agarwal, Rajiv; Pitt, Bertram; Palmer, Biff F; Kovesdy, Csaba P; Burgess, Ellen; Filippatos, Gerasimos; Małyszko, Jolanta; Ruilope, Luis M; Rossignol, Patrick; Rossing, Peter; Pecoits-Filho, Roberto; Anker, Stefan D; Joseph, Amer; Lawatscheck, Robert; Wilson, Daniel; Gebel, Martin; Bakris, George L

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

非奈利酮在患有慢性肾病和 2 型糖尿病的西班牙裔患者中的应用:一项事后 FIDELITY 分析

Rosas, Sylvia E; Ruilope, Luis M; Anker, Stefan D; Pitt, Bertram; Rossing, Peter; Bonfanti, Andres Angelo Cadena; Correa-Rotter, Ricardo; González, Fernando; Munoz, Carlos Francisco Jaramillo; Pergola, Pablo; Umpierrez, Guillermo E; Scalise, Andrea; Scott, Charlie; Lawatscheck, Robert; Joseph, Amer; Bakris, George L

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

非奈利酮治疗黑人2型糖尿病合并慢性肾病患者:FIDELIO-DKD和FIGARO-DKD试验汇总的事后分析

Flack, John M; Agarwal, Rajiv; Anker, Stefan D; Pitt, Bertram; Ruilope, Luis M; Rossing, Peter; Adler, Sharon G; Fried, Linda; Jamerson, Kenneth; Toto, Robert; Brinker, Meike; Farjat, Alfredo E; Kolkhof, Peter; Lawatscheck, Robert; Joseph, Amer; Bakris, George L